CAR-T Therapy May Carry Small Risk of Blood Cancer, FDA Says

The gene therapy could cause T-cells to become malignant.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Lifesaving CAR-T Therapy May Carry Small Risk of Blood Cancer, FDA Says While scientists have long suspected that the gene therapy could cause T-cells to become malignant, there have been no suspected cases of that happening until now. Learn more about the benefits and risks of CAR-T therapy. READ MORE New Research Re-examines the Cause of a Red Wine Headache Blood Clot Risk From Birth Control: New Study Shows It's Reversible Each product we feature has been independently selected and reviewed by our editorial team. If you make a purchase using the links included, we may earn commission. Unsubscribe from Membership Updates This email was sent to nanasmile27.globalnews@blogger.com Was this email forwarded to you? Subscribe here A DOTDASH MEREDITH BRAND 225 Liberty St, 4th Floor, New York, NY 10281 ©2023. All Rights Reserved. Privacy Policy  |  Terms of Service